Menu Search
Equities

PsyBio Therapeutics Corp

PSYB:STU

PsyBio Therapeutics Corp

Actions
  • Price (EUR)0.0005
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change0.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 27 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2022, PsyBio Therapeutics Corp increased its cash reserves by 26.42%, or 32.87k. Cash Flow from Investing totalled 3.52m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 3.44m for operations while cash used for financing totalled 54.98k.
Cash flow per share-0.0307
Price/Cash flow per share--
Book value per share-0.018
Tangible book value per share-0.018
More ▼

Balance sheet in USDView more

PsyBio Therapeutics Corp uses little or no debt in its capital structure.
Current ratio0.0537
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.